
Fully-developed technology for the manufacture of recombinant human granulocyte colony stimulating factor (G-CSF).
Patent Number: 1336/MUM/2007
Patent Title :Process for the preparation of granulocyte colony-stimulating factor
Out-licensing of technology for recombinant G-CSF derived from E. coli * Registration of rHu G-CSF in non-regulated markets * Scouting for partners in Europe who will take full responsibility for registering one or more of the following products [Viz.: Recombinant human G-CSF, rIFN-alpha 2b, erythropoietin (EPO)] * Marketing tie-ups.
Mr. Milan Doshi
Asst General Manager
Business Development
Research driven, human biotherapeutics company focused on rDNA products offering out-licensing of biogeneric bulk-API and finished formulations, contract research and contract manufacturing services.
View profile